Where will Catalyst be speaking next?


Nancy Bradish Myers will present a talk Accelerated Approval Standards: Application Gene Therapy as part of a panel entitled From Accelerated Approval to Reimbursement at the American Society for Gene and Cell Therapy Policy Summit 2021. She will then serve on a panel with: Renu Vaish, Kite Pharma, Ani Khachatourian, PharmD, Highmark Blue Cross Blue Shield, Richard White, National Organization for Rare Disorders (NORD) and Moderator: Jocelyn Ulrich, Pharmaceutical Research and Manufacturers of America (PhRMA).

Where has Catalyst spoken recently?


“Improving Access to Medicines: Exploring New Regulatory Frameworks for Letting Data Lead the Way to Increased Drug Options”
Moderator: Nancy Bradish Myers
March 18, 2021 — DIA Europe 2021, virtual


“What’s Next for the FDA in the Biden Administration?”
Presenter: Nancy Bradish Myers
December 16, 2020 — Rising Leaders Conference, virtual


Informa Pharma Intelligence
COVID-19 24-hour Webinar Series Event: Lessons Learned and a Path Forward

Presenter, Nancy Bradish Myers – Washington, DC
July 21, 2020


“Gene Therapy Manufacturing: How Can Innovation Help Overcome This Anticipated Hurdle?”
Moderator, Nancy Bradish Myers — Washington, DC
June 15, 2020 — DIA Annual Meeting


“Drug Pricing and Transparency: Upcoming Issues in Medicaid”
Presenter, Jeff M. Myers — Alexandria
February 28th — Medicaid Managed Care Summit


Catalyst and The Pink Sheet Explore the Impact of Past, Present and Future FDA Commissioners
Presenter, Nancy Bradish Myers – Washington, DC
Oct. 22, 2019


“Hot Topics in Digital Health: How is FDA’s Approach Evolving, and What Do Industry and Patients Need to Know?”
Moderator, Nancy Bradish Myers – San Diego
June 2019 – DIA Annual Meeting


“FDA in the Post-Gottlieb Era”
Presenter, Nancy Bradish Myers – Washington, DC
May 2019 – Rising Leaders Conference on Healthcare Policy


“FDA Basics: Structure, Authorities & Hot Topics”
Presenter, Nancy Bradish Myers – Washington, DC
April 12, 2019 — University of Tennessee: Executive MBA Program (The Washington Campus)


Changes in the Political Landscape Impacting Pharma and Bio Regulations
Panelist, Nancy Bradish Myers – Washington, DC
December 2018 – FDA/CMS Summit


“2018 Policy Mash-Up: New Shifts in the Healthcare Market and What They May Mean for Patients and the Biopharma Industry”
Moderator, Nancy Bradish Myers – Boston
June 2018 – DIA 2018 Annual Meeting


“Real-World Evidence (RWE) in drug development”
Panelist, Nancy Bradish Myers – Beijing, China
May 2018 – 10th DIA China Annual Meeting


“The impact of new leadership and new initiatives at FDA”
Panelist, Nancy Bradish Myers — San Francisco
January 2018 — Biotech Showcase


“Regulating the Digital Health Revolution: When does it help or hinder innovation?”
Panelist, Nancy Bradish Myers — San Francisco
January 2018 — Digital Medicine & Medtech Showcase


“CRISPR – Regulatory Challenges in the Gene Editing Revolution”
Moderator/presenter Nancy Bradish Myers (panel) — Chicago
June 2017 — DIA 2017 annual meeting


 “Regulatory Frameworks: How Can Regulators Facilitate Disruptive Innovation?”
Moderator/presenter Nancy Bradish Myers (panel) — Chicago
June 2017 — DIA 2017 annual meeting


Keynote speech on FDA and the Trump Administration
Nancy Bradish Myers, Florham Park, NJ
May 2017: RxAdherence 2017, Strategies to Improve Outcomes conference


 “The Trump Administration – What to Expect From the FDA”
Panelist, Nancy Bradish Myers — San Francisco
January 2017: Biotech Showcase annual meeting


 “The Future of Big Data”
Moderator/presenter, Nancy Bradish Myers — Philadelphia
June 2016: DIA 2016 annual meeting — Panel, DIAmond Session

For a full list of Catalyst speaking engagements over the past few years, please see our Events Archive.